
ICONICLABSPLC
NOTESTOTHEFINANCIALSTATEMENTS
FORTHEYEARENDED30JUNE2021
Page53
14. ShareCapital
30June2021 30June2020
Number £ Number £
Authorised, allotted and fully paid –
classifiedasequity
Ordinarysharesof£0.0025each‐‐‐‐
Ordinarysharesof£0.00001each 37,405,248,039 374,052 6,248,241,015 62,482
Deferredsharesof£0.00249each 1,637,129,904 4,076,454 1,637,129,905 4,076,454
Total 39,042,377,943
4,450,506 7,885,370,920 4,138,936
At 1 July 2020 the company had 6,248,241,015 Ordinary shares of £0.00001 in issue. During the period, the
companyissued31,166,999,985Ordinarysharesof£0.00001asfollows:
13July2020–2,000,000,000sharesissued,atapremiumof0.008ppershare;
30July2020–1,555,555,554sharesissued,
atapremiumof0.008ppershare;
17August2020–1,857,142,857sharesissued,atapremiumof0.006ppershare;
2September2020–2,428,571,428sharesissued,atapremiumof0.006ppershare
14September2020–3,428,571,428sharesissued,atapremiumof0.006pper
share;
25September2020–5,000,000,000sharesissued,atapremiumof0.006ppershare;
14October2020–4,555,555,555sharesissued,atapremiumof0.008ppershare;
16October2020–2,100,000,000sharesissued,atapremiumof0.009ppershare;
16October2020
–1,999,999,999sharesissued,atapremiumof0.006ppershare;and
20November2020–6,231,610,203sharesissued,atapremiumof0.011ppershare.
At30June2021,thecompanyhad37,405,248,039Ordinarysharesof£0.00001inissue.
InaccordancewiththeCompaniesAct2006,thecompanyhas
nolimitonitsauthorisedsharecapital.
Pursuanttoaresolutionpassedon16June2016,theCompanyresolvedthat:
The directors be generally authorised in accordance with the Articles to exercise all powers of the
companytoallotOrdinaryshares,orgrantrightstosubscribefor,orconvert
anysecurityintoOrdinary
shares,up toamaximum aggregatenominal valueof £500,000,providedalways thatsuch authority
conferredonthedirectorsshall(unlesspreviouslyrenewed,variedorrevokedpriortothattime)expire
attheconclusionofthecompany’snextannualgeneralmeetingoronthedatefalling18
monthsafter
thedateofthepassingoftheresolution,whicheveristhesooner.Thecompanymaymakeanofferor
agreement which would or might require Ordinary shares to be allotted pursuant to the resolution
referredtoinparagraph3.6.1ofthelistingprospectusbeforetheexpiryoftheir
authoritytodoso,but
allottheOrdinarysharespursuanttoanysuchofferoragreementafterthatexpirydate.
Allpre‐emptionrightsintheArticles tobewaived;(i)forthepurposesof,or inconnectionwith,the
Placing,theissueoftheConversionsharesand theissue
oftheWarrantshares;(ii)generallyforsuch
purposesas thedirectors may thinkfit(including theallotment ofequity securitiesfor cash)uptoa
maximumaggregateamountof£40,543.54;and(iii)forthepurposesoftheissueofsecuritiesoffered
(bywayofarightsissue,openoffer
orotherwise)toexistingholdersofOrdinaryshare,butsubjectto
the directors having a right to make such exclusions or other arrangements in connection with the
offering as they deem necessary or expedient; (A) to deal with the equity securities representing
fractionalentitlements;and(B)todealwithlegalor
practicalproblemsinthelawsofanyterritory,or
the requirements of any regulatory body; on the basis that the authorities conferred under the
resolution referred to in paragraph 3.6.2 of the listing prospectus shall (unless previously renewed,
varied or revoked prior to that time) expire at the conclusion of
the company’s next annual general
meetingoronthedatefalling18monthsafterthedateofthepassingoftheresolution,whicheveris
the sooner. The company may make an offer or agreement which would or might require equity
securitiestobeissuedbeforetheexpiryofitspowerto
doso,butallottheequitysecuritiespursuant
toanysuchofferoragreementafterthatexpirydate.